• 1
    Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713723.
  • 2
    Solez K, Racusen LC, Marcussen N et al. Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int 1993; 43: 10581067.
  • 3
    Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411422.
  • 4
    Jabs WJ, Sedlmeyer A, Ramassar V et al. Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice. Am J Transplant 2003; 3: 15011509.
  • 5
    Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplantation 1996; 61: 15861592.
  • 6
    Robertson H, Wheeler J, Kirby JA, Morley AR. Renal allograft rejection–in situ demonstration of cytotoxic intratubular cells. Transplantation 1996; 61: 15461549.
  • 7
    Einecke G, Melk A, Ramassar V et al. Expression of CTL associated transcripts precedes the development of tubulitis in T-cell mediated kidney graft rejection. Am J Transplant 2005; 5: 18271836.
  • 8
    Halloran PF, Urmson J, Ramassar V et al. Lesions of T-cell-mediated kidney allograft rejection in mice do not require perforin or granzymes A and B. Am J Transplant 2004; 4: 705712.
  • 9
    Cepek KL, Shaw SK, Parker CM et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature 1994; 372: 190193.
  • 10
    Higgins JMG, Mandlebrot DA, Shaw SK et al. Direct and regulated interaction of integrin alpha(E)beta(7) with E-cadherin. J Cell Biol 1998; 140: 197210.
  • 11
    Kutlesa S, Wessels JT, Speiser A, Steiert I, Muller CA, Klein G. E-cadherin-mediated interactions of thymic epithelial cells with CD103+ thymocytes lead to enhanced thymocyte cell proliferation. J Cell Sci 2002; 115:45054515.
  • 12
    Kilshaw PJ, Murant SJ. Expression and regulation of beta 7(beta p) integrins on mouse lymphocytes: Relevance to the mucosal immune system. Eur J Immunol 1991; 21: 25912597.
  • 13
    Schon MP, Arya A, Murphy EA et al. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol 1999; 162: 66416649.
  • 14
    Robertson H, Kirby JA. Post-transplant renal tubulitis: The recruitment, differentiation and persistence of intra-epithelial T cells. Am J Transplant 2003; 3: 310.
  • 15
    Aplin AE, Howe A, Alahari SK, Juliano RL. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharm Rev 2001; 50: 197263.
  • 16
    Schock F, Perrimon N. Molecular mechanisms of epithelial morphogenesis. Annu Rev Cell Dev Biol 2002; 18: 463493.
  • 17
    Mcneill H, Ozawa M, Kemler R, Nelson WJ. Novel Function of the Cell-Adhesion Molecule Uvomorulin As An Inducer of Cell-Surface Polarity. Cell 1990; 62: 309316.
  • 18
    Bai Y, Pontoglio M, Hiesberger T, Sinclair AM, Igarashi P. Regulation of kidney-specific Ksp-cadherin gene promoter by hepatocyte nuclear factor-1 beta. Am J Physiol Renal Physiol 2002; 283:F839F851.
  • 19
    Thomson RB, Aronson PS. Immunolocalization of Ksp-cadherin in the adult and developing rabbit kidney. Am J Physiol Renal Physiol 1999; 277: F146F156.
  • 20
    Robertson H, Wong WK, Talbot D, Burt AD, Kirby JA. Tubulitis after renal transplantation: Demonstration of an association between CD103+ T cells, transforming growth factor beta1 expression and rejection grade. Transplantation 2001; 71: 306313.
  • 21
    Hadley GA, Charandee C, Weir MR, Wang D, Bartlett ST, Drachenberg CB. CD103+ CTL accumulate within the graft epithelium during clinical renal allograft rejection. Transplantation 2001; 72: 15481555.
  • 22
    Feng Y, Wang D, Yuan R, Parker CM, Farber DL, Hadley GA. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells. J Exp Med 2002; 196: 877886.
  • 23
    Yuan R, El Asady R, Liu K, Wang D, Drachenberg CB, Hadley GA. Critical role for CD103+CD8+ effectors in promoting tubular injury following allogeneic renal transplantation. J Immunol 2005; 175: 28682879.
  • 24
    Halloran PF, Miller LW, Urmson J et al. IFN-gamma alters the pathology of graft rejection: Protection from early necrosis. J Immunol 2001; 166: 70727081.
  • 25
    Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response: Evidence for induction of interferon-γ, transforming growth factorβ-1, granulocyte-macrophage colony-stimulating factor, interleukin-2 and interleukin-10. Transplantation 1995; 59: 565572.
  • 26
    Takeuchi O, Sims TN, Takei Y, Ramassar V, Famulski KS, Halloran PF. Differential usage of class II transactivator promoters PI and PIV during inflammation and injury in kidney. J Am Soc Nephrol 2003; 14: 28232832.
  • 27
    Hadley GA, Rostapshova EA, Gomolka DM et al. Regulation of the epithelial cell-specific integrin, CD103, by human CD8+ cytolytic T lymphocytes. Transplantation 1999; 67: 14181425.
  • 28
    Eger A, Stockinger A, Schaffhauser B, Beug H, Foisner R. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J Cell Biol 2000; 148: 173188.
  • 29
    Vongwiwatana A, Tasanarong A, Rayner DC, Melk A, Halloran PF. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: The role of tubular cells in fibrogenesis. Am J Transplant 2005; 5: 13671374.
  • 30
    McGuire JK, Li Q, Parks WC. Matrilysin (Matrix Metalloproteinase-7) Mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 2003; 162: 18311843.
  • 31
    Noe V, Fingleton B, Jacobs K et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001; 114: 111118.
  • 32
    Bush KT, Tsukamoto T, Nigam SK. Selective degradation of E-cadherin and dissolution of E-cadherin- catenin complexes in epithelial ischemia. Am J Physiol Renal Physiol 2000; 278: F847F852.
  • 33
    Keller SH, Nigam SK. Biochemical processing of E-cadherin under cellular stress. Biochem Biophys Res Commun 2003; 307: 215223.
  • 34
    Yap AS, Kovacs EM. Direct cadherin-activated cell signaling: A view from the plasma membrane. J Cell Biol 2003; 160: 1116.
  • 35
    Conacci-Sorrell M, Zhurinsky J, Ben Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002; 109: 987991.
  • 36
    Lefrancois L, Parker CM, Olson S, Muller W, Wagner N, Puddington L. The role of beta 7 integrins in CD8 T cell trafficking during an antiviral immune response. J Exp Med 1999; 189: 16311638.
  • 37
    Martinez OM, Krams SM. Involvement of Fas-Fas ligand interactions in graft rejection. Int Rev Immunol 1999; 18: 527546.